<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03570645</url>
  </required_header>
  <id_info>
    <org_study_id>20180616</org_study_id>
    <nct_id>NCT03570645</nct_id>
  </id_info>
  <brief_title>Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block</brief_title>
  <official_title>Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block in Patients Undergoing Video-assisted Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was a prospective, randomized, controlled, and double-blind trial. Major
      assessments were made during the operation and 48 h postoperatively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prime outcomes were the time in minutes from leave the postoperative care unit to the
      first patient-controlled intravenous analgesia press.The secondary outcomes were to compare
      the following: (1)blood concentrations of ropivacaine was measured at 0.5 h, 1 h, 2 h, 3 h,
      and 24 h after paravertebral nerve block; and (2) the patient's intraoperative opioid use,
      phenylephrine use, fluid intake, urine output, dry mouth score, and 24 h and 48 h visual
      analogue scale.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 12, 2019</start_date>
  <completion_date type="Actual">November 18, 2019</completion_date>
  <primary_completion_date type="Actual">November 11, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine or dexamethasone</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of thoracic paravertebral block analgesia duration</measure>
    <time_frame>Change from Baseline to 2 days after surgery</time_frame>
    <description>The prime outcomes were the time in minutes from leave the postoperative care unit to the first patient-controlled intravenous analgesia press</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood concentrations of ropivacaine</measure>
    <time_frame>Change from Baseline to 2 days after surgery</time_frame>
    <description>(The secondary outcomes were to compare the following: (1)blood concentrations of ropivacaine was measured at 0.5 h, 1 h, 2 h, 3 h, and 24 h after paravertebral nerve block; and (2) the patient's intraoperative opioid use, phenylephrine use, fluid intake, urine output, dry mouth score, and 24 h and 48 h visual analogue scale.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine 100 ug every time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexamethasone Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>thoracic paravertebral blocks using a combination of ropivacaine and dexamethasone 10 mg every time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>thoracic paravertebral blocks using only ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine Group</intervention_name>
    <description>combination of ropivacaine and dexmedetomidine 100 ug every time</description>
    <arm_group_label>dexmedetomidine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexamethasone group</intervention_name>
    <description>combination of ropivacaine and dexamethasone 10mg every time</description>
    <arm_group_label>dexamethasone Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>control group</intervention_name>
    <description>block with only ropivacaine</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (1) age 18 to 65 years,

          -  (2) scheduled to undergo video-assisted thoracic surgery,

          -  (3) American Society of Anesthesiologists risk classification I-II.

        Exclusion Criteria:

          -  (1) patient refusal;

          -  (2) known hypersensitivity to the study medication (ropivacaine);

          -  (3) long-term use of opioids;

          -  (4) liver or renal insufficiency;

          -  (5) a history of psychiatric or neurological disease;

          -  (6) deafness;

          -  (7) regular use of acetaminophen, nonsteroidal anti-inflammatory drugs,
             corticosteroids, or antiemetics; and

          -  (8) a preoperative Pittsburgh Sleep Quality Index (PSQI) global score higher than 6.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology, the First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 16, 2018</study_first_submitted>
  <study_first_submitted_qc>June 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2018</study_first_posted>
  <last_update_submitted>November 18, 2019</last_update_submitted>
  <last_update_submitted_qc>November 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Wen-fei Tan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

